Insider Transactions by Morosini Deborah

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
PRLDPrelude Therapeutics IncMorosini DeborahEVP, Chief of Clinical AffairsDec 15, 2021Sale$13.0028,751373,763444Dec 17, 2021, 05:20 PM
PRLDPrelude Therapeutics IncMorosini DeborahEVP, Chief of Clinical AffairsDec 15, 2021Option Exercise$11.7028,751336,39529,195Dec 17, 2021, 05:20 PM
PRLDPrelude Therapeutics IncMorosini DeborahEVP, Chief of Clinical AffairsNov 16, 2021Option Exercise$12.8528,751369,45029,195Nov 18, 2021, 06:42 PM
PRLDPrelude Therapeutics IncMorosini DeborahEVP, Chief of Clinical AffairsNov 16, 2021Sale$15.8828,751456,532844Nov 18, 2021, 06:42 PM
PRLDPrelude Therapeutics IncMorosini DeborahEVP, Chief of Clinical AffairsApr 29, 2021Option Exercise$1.893,2236,0913,667Apr 30, 2021, 06:22 PM
PRLDPrelude Therapeutics IncMorosini DeborahEVP, Chief of Clinical AffairsApr 29, 2021Sale$40.293,223129,853444Apr 30, 2021, 06:22 PM
PRLDPrelude Therapeutics IncMorosini DeborahEVP, Chief of Clinical AffairsApr 08, 2021Sale$40.001004,000444Apr 15, 2021, 07:11 PM
PRLDPrelude Therapeutics IncMorosini DeborahEVP, Chief of Clinical AffairsApr 08, 2021Option Exercise$1.89100189544Apr 15, 2021, 07:11 PM
PRLDPrelude Therapeutics IncMorosini DeborahEVP, Chief of Clinical AffairsApr 07, 2021Option Exercise$1.891,0001,8901,444Apr 09, 2021, 05:52 PM
PRLDPrelude Therapeutics IncMorosini DeborahEVP, Chief of Clinical AffairsApr 07, 2021Sale$40.041,00040,043444Apr 09, 2021, 05:52 PM
PRLDPrelude Therapeutics IncMorosini DeborahEVP, Chief of Clinical AffairsSep 29, 2020Buy$19.004448,436444Sep 29, 2020, 08:08 PM